[go: up one dir, main page]

About: Netarsudil/latanoprost

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Netarsudil/latanoprost, sold under the brand name Rocklatan among others, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. It contains netarsudil mesylate and latanoprost. It is applied as eye drops to the eyes. Netarsudil/latanoprost was approved for medical use in the United States in March 2019, and in the European Union in January 2021.

Property Value
dbo:abstract
  • Netarsudil/latanoprost, sold under the brand name Rocklatan among others, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. It contains netarsudil mesylate and latanoprost. It is applied as eye drops to the eyes. The most common side effects include conjunctival hyperaemia (red eye), pain at the site where the medicine was applied, cornea verticillata (deposits in the cornea, the transparent layer in front of the eye that covers the pupil and iris), pruritus (itching of the eye), erythema (reddening) and discomfort in the eye, increased lacrimation (watery eyes), and conjunctival haemorrhage (bleeding in the surface layer of the eye). Netarsudil/latanoprost was approved for medical use in the United States in March 2019, and in the European Union in January 2021. (en)
dbo:alternativeName
  • Rocklatan, Roclanda (en)
dbo:kegg
  • D11558
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 64157845 (xsd:integer)
dbo:wikiPageLength
  • 5366 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1071750591 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • S01 (en)
dbp:atcSuffix
  • EE51 (en)
dbp:class
dbp:component
  • Latanoprost (en)
  • Netarsudil (en)
dbp:dailymedid
  • Netarsudil_and_latanoprost (en)
dbp:kegg
  • D11558 (en)
dbp:legalEu
  • Rx-only (en)
dbp:legalUs
  • Rx-only (en)
dbp:routesOfAdministration
dbp:tradename
  • Rocklatan, Roclanda (en)
dbp:type
  • combo (en)
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Netarsudil/latanoprost, sold under the brand name Rocklatan among others, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. It contains netarsudil mesylate and latanoprost. It is applied as eye drops to the eyes. Netarsudil/latanoprost was approved for medical use in the United States in March 2019, and in the European Union in January 2021. (en)
rdfs:label
  • Netarsudil/latanoprost (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License